Join us in Basel for an immersive event focused on sustainable, innovative healthcare practices. Engage with keynotes and panels featuring transformative solutions to clinical research and patient care challenges. Our representatives will highlight our latest projects and invite discussions on driving collaborative initiatives forward. From advancing patient safety to integrating digital innovations, DIA Europe promises a comprehensive agenda. Schedule a meeting with our team to explore partnership opportunities.
Richmond supports Beam Therapeutics to make significant step forward in potential one-time gene editing treatment for Alpha-1
March 30, 2026
Beam Therapeutics has announced compelling updated clinical data from its ongoing Phase 1/2 Trial of BEAM-302 as a potential treatment for Alpha-1 Antitrypsin Deficiency (AATD).
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
.svg){kind=small}
.avif)
